# ICU Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
Canonical URL: https://biopharmsignal.com/news/ICUI/icu-medical-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-4c26b720
Ticker: ICUI
Company: ICU Medical
Source: ICU Medical
Published: 2025-12-31 13:30 EST
## Summary

ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative...

## Article Body
ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the 44th Annual J.P. Morgan Healthcare Conference being held in San Francisco, California, January 12-15, 2026. ICU Medical’s presentation will be on Wednesday, January 14, 2026 at 1:30 p.m. PT (4:30 p.m. ET). Company management will also be participating in one-on-one meetings on Wednesday, January 14, 2026.

The presentation will be webcast live and can be accessed by going to the Company’s website at http://www.icumed.com , clicking on the Investors tab and clicking on the Event Calendar tab. The webcast will also be available by replay.

About ICU Medical

ICU Medical (Nasdaq: ICUI) is a global leader in infusion systems, infusion consumables and high-value critical care products used in hospital, alternate site and home care settings. Our team is focused on providing quality, innovation and value to our clinical customers worldwide. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical can be found at www.icumed.com .

CONTACT: ICU Medical Brian Bonnell, Chief Financial Officer (949) 366-2183

ICR, Inc. John Mills, Managing Partner (646) 277-1254

Source: ICU Medical, Inc.
## Recent Company News
- 2026-07-23 12:30 EST — [ICU Medical Announces Time of Second Quarter 2026 Earnings Conference Call](https://biopharmsignal.com/news/ICUI/icu-medical-announces-time-of-second-quarter-2026-earnings-conference-call-20153c86) — Source: ICU Medical
- 2026-05-07 20:05 EST — [ICU Medical Announces First Quarter 2026 Results](https://biopharmsignal.com/news/ICUI/icu-medical-announces-first-quarter-2026-results-5829e642) — Source: ICU Medical
- 2026-04-23 12:30 EST — [ICU Medical Announces Time of First Quarter 2026 Earnings Conference Call](https://biopharmsignal.com/news/ICUI/icu-medical-announces-time-of-first-quarter-2026-earnings-conference-call-6e434179) — Source: ICU Medical
- 2026-02-23 13:30 EST — [ICU Medical to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/ICUI/icu-medical-to-participate-in-upcoming-investor-conferences-7eb475f2) — Source: ICU Medical
- 2026-02-19 21:05 EST — [ICU Medical Announces Fourth Quarter 2025 Results and Provides Fiscal Year 2026 Guidance](https://biopharmsignal.com/news/ICUI/icu-medical-announces-fourth-quarter-2025-results-and-provides-fiscal-year-2026--0e1ae898) — Source: ICU Medical
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)